Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

Completed · Phase 1

Conditions studied: Melanoma (Skin)

In brief

Phase I trial to study the effectiveness of vaccine therapy in treating patients who have unresectable metastatic melanoma. Vaccines may make the body build an immune response to kill tumor cells.

Key facts

Study ID

NCT00004148

Run by

National Cancer Institute (NCI)

People needed

12

Starts

1999-10-01

Last updated by the study team

2013-02-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.